On-demand
The Changing Landscape for Biopharma
How to Deliver the Right People in Critical Roles to Drive Strategic Execution
Critical roles in the biopharma industry – like Market Access, Medical Directors, and Product Leads – are becoming more complex, with rising need for new leadership expectations, culture changes and mindset shifts, and succession planning.
The pressure is on for talent leaders and company executives to figure out how to reorient development, build bench strength, and deliver a talent strategy to keep pace with the demands of rapidly evolving business strategy.
This exclusive peer event brings together senior business leaders from various industries to exchange insights, ideas, and experiences, inspiring one another to lead with a fresh perspective.
In this roundtable conversation, we are convening a set of biopharma talent leaders to share insights and challenges.
Play Video
Featured Panelists
Curran Brugger
VP Talent, Development & Inclusion, Gilead Sciences
José H. David, Ph.D.
Executive Director, Learning and Development, Merck
Lynda Libby
Executive Director and Head, R&D Center of Operational Performance, Takeda
Lloyd Hilton
Strategy Performance & Execution Lead, Amgen
We'll explore
- How to recruit for these important positions
- Ways to target new leadership capabilities
- How to approach critical role succession
- Best practices for engaging and retaining those in critical roles
Hosted by
Lance Wilke
SVP, Head of Talent, Learning, & Leadership, BTS
Lynn Collins, Ph.D.
Head of Assessment North America, BTS
Who should attend
Senior level business and functional leaders with responsibility for driving impact, transformation and change for enterprise or business units.
Questions about this event
Reach out to events.northamerica@bts.com